Thromboprophylaxis Not Effective After Knee Arthroplasty, Casting

This article originally appeared here.
Share this content:
Thromboprophylaxis Not Effective After Knee Arthroplasty, Casting
Thromboprophylaxis Not Effective After Knee Arthroplasty, Casting

MONDAY, Dec. 5, 2016 (HealthDay News) -- The use of thromboprophylaxis seems not to prevent venous thromboembolism after knee arthroplasty or casting of the lower leg, according to a study published online Dec. 3 in The New England Journal of Medicine.

Raymond A. van Adrichem, M.D., from Leiden University Medical Center in the Netherlands, and colleagues conducted two parallel multicenter randomized trials with blinded outcome evaluation: the POT-KAST trial involving patients undergoing knee arthroscopy and the POT-CAST trial involving patients treated with casting of the lower leg. Patients were randomized to receive a prophylactic dose of low-molecular-weight heparin or no anticoagulant therapy.

The researchers found that venous thromboembolism occurred in 0.7 percent of patients in the treatment group and in 0.4 percent of patients in the control group in the POT-KAST trial (relative risk, 1.6; 95 percent confidence interval, 0.4 to 6.8). Major bleeding occurred in 0.1 percent of patients in each group. Venous thromboembolism occurred in 1.4 percent of the treatment group and 1.8 percent of the control group in the POT-CAST trial (relative risk, 0.8; 95 percent confidence interval, 0.3 to 1.7). There were no major bleeding events.

"Prophylaxis with low-molecular-weight heparin for the eight days after knee arthroscopy or during the full period of immobilization due to casting was not effective for the prevention of symptomatic venous thromboembolism," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Recent Decline in Prescription Opioid Use Among U.S. Teens

Recent Decline in Prescription Opioid Use Among U.S. ...

Lifetime prevalence of use peaked in 1989, 2002, and remained stable until decline in 2013 to 2015

Treatment Seeking Low Among Teens With Eating Disorders

Treatment Seeking Low Among Teens With Eating Disorders

Those with counter-stereotypic presentation even less likely to seek treatment

Optical Clearing Agent Ups No. of Laser Passes in Tattoo Removal

Optical Clearing Agent Ups No. of Laser Passes ...

Findings based on number of laser passes during a five-minute tattoo removal session

is free, fast, and customized just for you!

Already a member?

Sign In Now »